Lung transplantation is the major focus of my clinical and research efforts. I am fascinated by the opportunities and the challenges in transplantation, particularly in developing new and extremely precise ways to diagnose potential tissue rejection using molecular methodology.
Lung transplant specialist Dr. Kieran Halloran received his medical degree from the University of Alberta. He completed respirology and internal medicine fellowships, also at the University of Alberta, followed by a lung transplantation clinical fellowship at the University of Toronto. Dr. Halloran received a Master of Science in Epidemiology degree from Harvard University. He was appointed assistant professor at the University of Alberta in 2015.
Leadership and Collaborations:
Dr. Halloran is medical co-chair of the Transplant Council for Connect Care, member of the Alberta Transplant Institute Education Committee and of the Alberta Respirology Centre Strategic Planning Committee.
Dr. Halloran supervises all levels of clinical and research trainees. He provides classroom and clinical instruction to medical students, core medicine residents and pulmonary fellows, as well as continuing medical education sessions in lung transplantation. He also supervises research trainees at the undergraduate and post-graduate level.
Dr. Halloran’s research is supported by international, provincial and local funding bodies and delves into pre-transplant risk prediction, phenotyping of post-transplant lung dysfunction and molecular mechanisms of lung rejection. His research findings have been published in articles and abstracts in such peer-reviewed journals as Journal of Heart and Lung Transplantation, Transplantation, American Journal of Respiratory Critical Care Medicine and American Journal of Transplantation.
Diagnostics, Lung Transplant, Lung transplantation, Outcomes, Physiology, prediction
Dr. Halloran is a lung transplant specialist at the University of Alberta Hospital. His clinical areas of interest are pre-transplant risk prediction and phenotyping post-transplant lung dysfunction.